Syntone Ventures is a venture firm and a wholly-owned U.S.-based subsidiary of Syntone Technologies Group.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 26, 2020
Outlook Therapeutics
|
Post-IPO Equity | $27.20M | Biopharma | Yes |
Syntone Ventures has had 1 exits. Syntone Ventures most notable exits include Outlook Therapeutics
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
May 13, 2016 | Outlook Therapeutics | IPO | Biopharma | Detail |